I
onized calcium (Ca 2+ ) is a divalent cation essential for many biological functions ranging from coagulation to cardiac contraction. 1, 2 Thus, calcium homeostasis is tightly regulated, and derangements in calcium levels can be life threatening. 3, 4 Severe injuries challenge this homeostatic balance, likely through multiple mechanisms. These include altered parathyroid hormone release, deranged parathyroid hormone responsiveness, intracellular calcium sequestration, and calcium chelation by phosphate from tissue injury and citrate accumulation during a resuscitation requiring blood product transfusion. 4, 5 In both acutely injured patients and mixed populations of patients requiring massive transfusion, deranged calcium levels are associated with poor outcomes. [5] [6] [7] Whether this is a prognostic marker of illness severity or a causal factor is debated and likely varies at the individual patient level. Nonetheless, the association between observed calcium dysregulation, massive transfusion, and increased mortality has long been recognized. 8, 9 However, the degree of calcium dysregulation in severely injured patients and the impact of transfusion and calcium supplementation on calcium homeostasis remain poorly described. Multiple factors including the lack of details in the transfusion record regarding the timing of blood product administration, the failure to account for exogenous calcium supplementation, and the uncoupling of laboratory sample measurements from these critical interventions all serve to confound our ability to draw meaningful BACKGROUND: Admission hypocalcemia predicts both massive transfusion and mortality in severely injured patients. However, the effect of calcium derangements during resuscitation remains unexplored. We hypothesize that any hypocalcemia or hypercalcemia (either primary or from overcorrection) in the first 24 hours after severe injury is associated with increased mortality. METHODS: All patients at our institution with massive transfusion protocol activation from January 2013 through December 2014 were identified. Patients transferred from another hospital, those not transfused, those with no ionized calcium (Ca 2+ ) measured, and those who expired in the trauma bay were excluded. Hypocalcemia and hypercalcemia were defined as any level outside the normal range of Ca 2+ at our institution (1-1.25 mmol/L). Receiver operator curve analysis was also used to further examine significant thresholds for both hypocalcemia and hypercalcemia. Hospital mortality was compared between groups. Secondary outcomes included advanced cardiovascular life support, damage control surgery, ventilator days, and intensive care unit days. RESULTS: The massive transfusion protocol was activated for 77 patients of whom 36 were excluded leaving 41 for analysis. Hypocalcemia occurred in 35 (85%) patients and hypercalcemia occurred in 9 (22%). Mortality was no different in hypocalcemia versus no hypocalcemia (29% vs 0%; P = .13) but was greater in hypercalcemia versus no hypercalcemia (78% vs 9%; P < .01). Receiver operator curve analysis identified inflection points in mortality outside a Ca 2+ range of 0.84 to 1.30 mmol/L. Using these extreme values, 15 (37%) had hypocalcemia with a 60% mortality (vs 4%; P < .01) and 9 (22%) had hypercalcemia with a 78% mortality (vs 9%; P < .01). Patients with extreme hypocalcemia and hypercalcemia also received more red blood cells, plasma, platelets, and calcium repletion. CONCLUSIONS: Hypocalcemia and hypercalcemia occur commonly during the initial resuscitation of severely injured patients. Mild hypocalcemia may be tolerable, but more extreme hypocalcemia and any hypercalcemia should be avoided. Further assessment to define best practice for calcium management during resuscitation is warranted. (Anesth Analg 2017;125:895-901) conclusions on peri-injury calcium derangements and the appropriate management of these abnormalities. Thus, in this pilot investigation, we sought to more completely characterize calcium fluctuations during active resuscitation. Hypothesizing that any hypocalcemia or hypercalcemia (either primary or from overcorrection) within 24 hours of severe injury is associated with increased mortality.
METHODS
Following approval by the Hospital of the University of Pennsylvania Institutional Review Board, all trauma patients directly admitted through the trauma bay for whom the massive transfusion protocol (MTP) was activated from January 2013 through December 2014 were queried from an institutional trauma registry. MTP activation at our institution is prompted when the attending surgeon identifies a patient who is bleeding significantly but also has some chance of survival beyond the trauma bay. Exclusion criteria included patients who transferred from another institution, patients who expired in the trauma bay, patients with incomplete transfusion records, and patients in whom Ca Study data were obtained from both the institutional trauma registry and the electronic medical record (EMR). Data collected from the trauma registry included admission demographics, injury severity and mechanism, hemodynamic parameters, morbidities, and mortality. Details of the electrolyte trends and timing of transfusions over the first 24 hours of admission were obtained from the EMR. These included minimum Ca
2+
, maximum Ca 2+ , total calcium administered (either calcium chloride or calcium gluconate), total units of packed red blood cells (pRBC), fresh frozen plasma (FFP), and platelets (PLTs).
Our institutional MTP provides 6 units of pRBC, 6 units of FFP, and 1 aphaeresis unit of PLTs per round. In contrast to some institutions, there is no protocol for empiric or laboratory-guided calcium administration as part of our MTP. 10 It should be noted that at the time the resuscitation, neither TEG (Braintree, Massachusetts) nor ROTEM (Basel, Switzerland) was being used at our institution. Massive transfusion was defined as ≥10 units of pRBC in 24 hours or as receiving ≥3 units of pRBC over a single hour.
11 Total blood product units was defined as the sum of pRBC, FFP, and 6*PLT given in 24 hours.
Both hypocalcemia and hypercalcemia were evaluated. Hypocalcemia and hypercalcemia were defined using the institution laboratory reference range (low limit: Ca 2+ <1.0 mmol/L, high limit: ≥1.25 mmol/L) and by assessing the extreme Ca 2+ levels, which optimized sensitivity and specificity for mortality using the Youden index from the receiver operator curves. 12 For hypocalcemia, the lowest value in the range produced by the receiver operator curve analysis was selected while the highest value in the range was selected for hypercalcemia. The relationship between maximum and minimum Ca 2+ levels and total blood products administered was evaluated using scatterplots with total blood products on the x-axis and Ca 2+ levels on the y-axis and patients partitioned by outcome (alive versus dead).
Comparisons were performed using the Fisher exact test for categorical variables and Wilcoxon rank sum (Mann-Whitney) test for continuous variables. Data are presented as a number (n) and percentage (%) for categorical variables and median with interquartile range for continuous variables. Subsequently, a multivariable logistic regression analysis was undertaken to account for confounding data. Sample size for this pilot retrospective was a convenience sample based on available EMR data from the trauma bay, operating room, and surgical intensive care unit. All analyses and graphical representations were performed using STATA v13.0 (College Station, TX) and MATLAB (Natick, MA).
RESULTS
During the study period, MTP was activated for 77 severely injured patients. Of these, 36 were excluded leaving 41 for analysis ( Figure 1 ). Patients in the study cohort were predominately male with a penetrating mechanism of injury. These patients were severely injured with most patients requiring immediate operative intervention (Table 1) . Although all patients had an MTP activation, of those included for analysis, only 3 actually received an MT during the study period. The median total units of blood products transfused was 7 and median calcium supplementation was 0.5 g.
By laboratory definitions of abnormal calcium levels, 35 patients had hypocalcemia during the first 24 hours following injury, while 9 had hypercalcemia ( Table 1 ). The Youden index identified optimal Ca 2+ limits at more extreme levels of 0.84 mmol/L on the lower end and 1.3 mmol/L on the upper end. By these limits, 15 patients manifested extreme hypocalcemia (Table 1) , while there was no difference in the patients categorized as having extreme hypercalcemia (n = 9). Patients sorted by the degree of calcium derangement and the primary outcome, all-cause, in-hospital mortality are demonstrated in Figure 2 .
By univariable analysis, patients with laboratory-defined hypocalcemia (<1.0 mmol/L) versus no laboratory-defined hypocalcemia were more severely injured (Injury Severity Score 26 vs 10; P = .04). However, they received no more pRBC (5 vs 3; P = .12), FFP (2 vs 2; P = .73), PLT (1 vs 1; P = .82), or total blood product units (7 vs 5; P = .30). Likewise, there was no difference in need for advanced cardiovascular life support (20% vs 17%; P = 1.00), damage control surgery (51% vs 17%; P = .19), ventilator days (1 vs 1; P = .37), intensive care unit (ICU) days (3 vs 1; P = .24), or mortality (29% vs 0%; P = .31).
Patients with extreme hypocalcemia (<0.84 mmol/L) versus no extreme hypocalcemia were more severely injured, as quantified by Injury Severity Score (Table 1) . They received more pRBC, FFP, PLT, total units, and were more likely to receive a product transfusion ratio of (FFP + PLT)/(pRBC) ≥ 0.5 (Table 1) . These extreme hypocalcemic patients also received more calcium supplementation as compared to those without extreme hypocalcemia (Table 1) . Furthermore, mortality was significantly greater in those with extreme hypocalcemia (60% vs 4%; P < .01; Table 2 ). Scatterplot analysis illustrates the relationship between total units transfused in 24 hours and minimum ionized calcium ( Figure 3) .
Unlike in the case of extreme hypocalcemia (described above), the optimized definition of extreme hypercalcemia (≥1.30 mmol/L) did not narrow the number of patients with hypercalcemia in our cohort. Thus, all the patients with any hypercalcemia by the laboratory definition (≥1.25 mmol/L) also had extreme hypercalcemia. Patients with any hypercalcemia versus no hypercalcemia received more pRBC, FFP, PLT, total blood product units, and were more likely to meet the definition for massive transfusion (Table 1) . These patients had a significantly greater mortality (78% vs 9%; P < .01; Table 2 ). Scatterplot analysis illustrates the relationship between total units transfused in 24 hours and maximum ionized calcium (Figure 4) . A total of 8 patients had both extreme hypocalcemia and extreme hypercalcemia while 8 had only one or the other derangement (extreme hypocalcemia only, n = 7; extreme hypercalcemia only, n = 1) and 25 had no extreme derangements ( Figure 2 ). Those patients with both extreme hypercalcemia and hypocalcemia had a mortality of 75%. This was no different from those with only 1 calcium derangement (50%; P = .60) but was significantly greater than those with no derangement (0; P < .01).
A multivariable logistic regression analysis was undertaken in an attempt to control for the most significant confounder, blood product transfusion. With mortality as the outcome of interest, the variables of total units, minimum , did not find any single variable to be predictive of mortality (Table 4) .
DISCUSSION
The purpose of this investigation was to characterize calcium fluctuations during active trauma resuscitation and to determine if hypocalcemia that develops within 24 hours of severe injury or hypercalcemia which is either present on admission or results from overcorrection is associated with in-hospital mortality. This pilot analysis demonstrates 3 important findings. First, we found that laboratory-defined hypocalcemia was likely not a clinically useful marker of deranged calcium homeostasis. Conversely, a very slightly lower calcium level (<0.84 mmol/L) may be more clinically useful in this regard. Second, we found that any hypercalcemia either on presentation or from overcorrection by even the laboratory-defined limit is associated with increased mortality. Finally, mortality was greatest in those patients who received large volumes of blood products, a resuscitation ratio closer to 1:1:2 (FFP:PLT:pRBC) and whose calcium concentration significantly deviated from normal. However, if calcium levels remained within normal limits, even during massive resuscitation, mortality was lower. Calcium fluctuations during massive resuscitation have gained renewed attention in the recent literature. Indeed, the 2013 European Guidelines for the management of bleeding and coagulopathy following major injury recommend that ionized calcium be maintained at >0.9 mmol/L. 13 Furthermore, 3 recent studies have highlighted the significance of deranged calcium homeostasis in severely injured patients. 5, 7, 14 Magnotti et al 5 retrospectively evaluated preresuscitation ionized hypocalcemia on admission in 591 trauma activations over 9 months. Admission hypocalcemia (iCa 2+ < 1.00 mmol/L) occurred in 332 (56%) of patients, and these patients had a significantly greater mortality as compared to those without hypocalcemia (15.5% vs 8.7%; P = .036). Multivariable logistic regression revealed Ward et al 14 retrospectively performed a longitudinal analysis of calcium and albumin in 64 trauma ICU patients who survived at least 3 days to determine if distinctive patterns of calcium responsiveness could be ascertained. Interestingly, calcium trends over time were strongly associated with survival versus nonsurvival with a distinct pattern of calcium normalization seen in survivors.
Finally, Giancarelli et al 7 recently completed a detailed retrospective analysis of calcium levels, calcium repletion, and blood product resuscitation in 156 trauma patients who received a massive transfusion (>10 units pRBC/24 hours) over a 4-year period. In this study, calcium levels were measured multiple times during each resuscitation. Severe hypocalcemia (iCa 2+ <0.90 mmol/L) occurred in 111 (71%) patients at some point during the resuscitation. Of note, a median value of 4 units of blood products was given before the first calcium measurement in all patients. Those with severe hypocalcemia received significantly more pRBC, FFP, PLTs, and cryoprecipitate. Additionally, a total of 15 units of blood products was predictive of severe hypocalcemia. Finally, those with severe hypocalcemia had a much higher mortality (49% vs 24%; P < .01).
Our pilot, retrospective study aimed to investigate the characteristics of trauma patients at risk for developing ionized hypo-or hypercalcemia, hypothesizing that derangements in ionized calcium could have an association with mortality. The primary strength of this investigation was the collection and subsequent analysis of transfusion and calcium data from multiple locations including the trauma bay, operating room, and surgical ICU. This allowed us to more fully characterize the dynamic nature of calcium fluctuations during the resuscitation. This detailed analysis illuminated the important fact that those who received a transfusion ratio higher in FFP and PLT (ie, an FFP + PLT/ RBC ratio of ≥0.5) are more likely to have extreme hypocalcemia. Since the PROMMTT 15 and the PROPPR 16 trials, resuscitation goals in trauma have changed and patients are receiving FFP and PLT earlier. Given that FFP and PLT contain a higher concentration of citrate compared to RBCs, resuscitationists should be aware of a potential earlier manifestation of ionized hypocalcemia.
There are several weaknesses of this investigation. The first of which is the retrospective nature of the study, focused on a convenience sample of patients in whom our MTP was activated. The second of which was the small sample size. Although a multivariable logistic regression analysis could be undertaken using continuous variables, controlling for blood product administration by FFP, PLT, and pRBC units did not illuminate predictors of mortality in this cohort. A larger sample size, with more outcome observations, would allow a multivariable logistic regression using categorized variables. For example, grouping minimum Ca 2+ (<0.84 vs ≥0.84 mmol/L), maximum Ca 2+ (<1.30 vs ≥1.30 mmol/L), and total units transfused (≥10 units/24 h vs <10 total units/24 h) could illuminate predictors more readily than using continuous variables. However, with a cohort this small, a multivariable logistic regression analysis would yield CIs too wide from which to derive a meaningful conclusion.
Ultimately, it remains unclear whether calcium dysregulation in patients undergoing large-volume blood product resuscitation is primarily driving mortality or is simply a manifestation of a deranged premorbid physiology. Furthermore, whether hypercalcemia on presentation or as a result of overcorrection independently increases mortality beyond the effect of extreme hypocalcemia alone cannot be determined from this retrospective analysis. In the meantime, trauma centers should consider dosing calcium empirically in severely injured patients followed by early and frequent assessments of serum calcium levels throughout the resuscitation to optimize the likelihood of achieving and maintaining normal calcium levels.
CONCLUSIONS
The findings of this pilot investigation demonstrate that both extreme hypocalcemia (Ca 2+ <0.84 mmol/L) and any hypercalcemia (Ca 2+ ≥1.25 mmol/L) occur commonly in severely injured patients undergoing large-volume blood product resuscitation and that both are associated with increased mortality. Whether these derangements have any causal role in these trauma deaths and whether maintaining or correcting calcium to normal levels improves survival
have not yet been determined. E 
